Artwork

Contenu fourni par NZME and Newstalk ZB. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par NZME and Newstalk ZB ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !

Christopher Luxon: Prime Minister on Pharmac receiving $604m in funding for new cancer drugs

10:27
 
Partager
 

Manage episode 425429125 series 2098285
Contenu fourni par NZME and Newstalk ZB. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par NZME and Newstalk ZB ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Prime Minister Christopher Luxon's praising himself for finally getting there with the cancer drug funding.

The Government's committing $604 million to Pharmac, taken from next year's Budget.

It will cover the funding for 54 new medicines, including up to seven of 13 drugs the Government promised last year.

The cancer medicines funded would treat cancer of the lung, liver, skin, bowel, kidney, head and neck, and bladder. The Government has also promised some of the drugs would combat breast and blood cancers.

The 28 non-cancer-related drugs would address a range of conditions likely to include infections, respiratory conditions, osteoporosis, sexual health, dermatology, inflammatory conditions, and mental health.

The spend was double what National proposed in 2023.

Luxon told Mike Hosking that he's proud of the investment and ultimately for delivering more than promised initially.

He says it's different from what was proposed but he's more interested in the outcomes, and he's now surpassed them.

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

  continue reading

5118 episodes

Artwork
iconPartager
 
Manage episode 425429125 series 2098285
Contenu fourni par NZME and Newstalk ZB. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par NZME and Newstalk ZB ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Prime Minister Christopher Luxon's praising himself for finally getting there with the cancer drug funding.

The Government's committing $604 million to Pharmac, taken from next year's Budget.

It will cover the funding for 54 new medicines, including up to seven of 13 drugs the Government promised last year.

The cancer medicines funded would treat cancer of the lung, liver, skin, bowel, kidney, head and neck, and bladder. The Government has also promised some of the drugs would combat breast and blood cancers.

The 28 non-cancer-related drugs would address a range of conditions likely to include infections, respiratory conditions, osteoporosis, sexual health, dermatology, inflammatory conditions, and mental health.

The spend was double what National proposed in 2023.

Luxon told Mike Hosking that he's proud of the investment and ultimately for delivering more than promised initially.

He says it's different from what was proposed but he's more interested in the outcomes, and he's now surpassed them.

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

  continue reading

5118 episodes

Toate episoadele

×
 
Loading …

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

 

Guide de référence rapide